Elekta nets FDA OK for VMAT update

Justine Varieur Cadet | July 27, 2009 | Health Imaging | Oncology Imaging

Elekta has received FDA 510(k) clearance for a volumetric modulated arc therapy (VMAT) enhancement to Monaco, its radiation therapy treatment planning solution.

According to the Stockholm, Sweden-based company, the Monaco system introduces a set of tools to make the treatment planning process easier. Its intensity modulated radiotherapy (IMRT) treatment planning system features constrained optimization and dose calculation algorithms.

Monaco has been available for use clinically for the past two years for step-and-shoot IMRT planning. The product was developed in cooperation with Eberhard Karls University Tuebingen in Germany.

Justine Varieur Cadet

Around the web

Radiology Business

Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business

‘A significant milestone’: First US patients receive doses of new PET radiotracer for CAD

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care.

Cardiovascular Business

Continuation of 99mTc-PYP shortage prompts need for alternative cardiac amyloidosis imaging

After three years of intermittent shortages of nuclear imaging tracer technetium-99m pyrophosphate, there are no signs of the shortage abating.

Elekta nets FDA OK for VMAT update

Related Content

Around the web